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Langerhans cells are bone marrow-derived epidermal
dendritic cells. They migrate out of the epidermis
into the lymphatics and travel to the draining lymph
nodes where they are responsible for the activation
of T cells in the primary immune response. Tumor
necrosis factor and interleukin-1b, have previously
been shown to be responsible for Langerhans cell
migration in response to contact sensitizers in
BALB/C mice; however, which cytokines are
responsible for mediating Langerhans cell migration
in response to a replicating cutaneously acquired
virus such as the West Nile Virus, are not known.
We have devised a method for identifying
Langerhans cells in the draining lymph nodes using
E-cadherin labeling and ¯ow cytometry. We infected
tumor necrosis factor-de®cient gene knockout mice
(tumor necrosis factor±/±) intradermally with West
Nile Virus and found that levels of Langerhans cell
emigration and accumulation in the draining lymph
nodes were similar to wild-type C57BL/6 mice. This
was borne out by the ®nding that high levels of sys-
temic neutralizing anti-tumor necrosis factor anti-
body failed to inhibit the migration of Langerhans
cells from the epidermis and their accumulation in
the draining lymph nodes in wild-type C57BL/6
mice. In West Nile Virus-infected, tumor necrosis
factor±/± mice treated with systemic neutralizing
anti-interleukin-1b antibodies, however, migration of
Langerhans cells from the epidermis and their accu-
mulation in the draining lymph nodes were signi®-
cantly inhibited compared with control antibody-
treated, infected animals. The results indicate that
Langerhans cell migration, accumulation in the
draining lymph nodes and the initiation of lymph
node shut-down in response to a cutaneous West
Nile Virus infection is dependent on interleukin-1b
and can occur in the absence of tumor necrosis
factor. Key words: cytokines/dendritic cells/E-cadherin/
epidermis/¯avivirus. J Invest Dermatol 117:702±709, 2001
L
angerhans cells are bone marrow-derived dendritic cells
(DC) that reside in the epidermis of the skin. They are
professional antigen-presenting cells, responsible for
activating naõÈve T cells in a primary immune response
to an antigen (Steinman, 1991).
Work with contact sensitizers shows that Langerhans cells take
up antigen and migrate from the skin to the local draining lymph
nodes where they present that antigen to T lymphocytes (Stingl
et al, 1978, 1980). It is less clear, however, what happens when a
replicating antigen such as an arthropod-borne ¯avivirus, is
deposited in the epidermis and dermis by the bite of an infected
mosquito or tick. It has recently been demonstrated that human
Langerhans cells are directly infected with a closely related
¯avivirus, Dengue (Wu et al, 2000). This group suggests that
Langerhans cells are the primary targets of ¯avivirus infection in the
skin. Such infection is common in many areas of the world, with
neurotropic ¯aviviruses, such as West Nile virus (WNV), St Louis
encephalitis, Murray Valley encephalitis, tick-borne encephalitis,
and Japanese encephalitis viruses, causing signi®cant morbidity and
mortality in both humans and animals. Some, such as WNV,
endemic in Third World Africa and India, cause serious periodic
epidemics outside these areas. An outbreak of WNV encephalitis
occurred for the ®rst time in New York in 1999 with 50
documented cases and at least ®ve fatalities (Anderson et al, 1999;
Briese et al, 1999; Lanciotti et al, 1999). The likelihood of
outbreaks of infection with these viruses in nonendemic areas has
increased markedly with tourism and as global warming extends the
environment permissive for the mosquito vector (Anderson et al,
1999; Hubalek and Halouzka, 1999).
Work from our laboratory has shown in vitro infection with
WNV is accompanied by cytokine-independent upregulation of
the major histocompatibility complex class I and II (MHC I, II)
antigens, the cellular adhesion molecules, CD54 (ICAM-1) and
CD106 (VCAM-1), and the selectin, CD62-E (E-selectin), vari-
ously, depending on the cell type (King and Kesson, 1988; Shen
et al, 1997). Furthermore, this virus-induced response is accom-
panied by an increased susceptibility to cytotoxic T cell lysis
(Douglas et al, 1994), consistent with increasing evidence for an
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immunopathologic basis for ¯avivirus disease (Bres, 1988; Andrews
et al, 1999).
More recently, therefore, our efforts have been directed at
de®ning the earliest events in the initiation of the immune response
to cutaneous WNV infection in an in vivo BALB/C mouse model.
We have found that epidermal Langerhans cells signi®cantly
increase expression of MHC II, ICAM-1, and the costimulatory
molecule, CD80 (B7-1) (Johnston et al, 1996), and migrate from
the epidermis to the local draining lymph nodes (Johnston et al,
2000). Others meanwhile have highlighted the importance of DC
in initiating an immune response speci®cally against viruses
(Ludewig et al, 1998).
Which factors induce epidermal Langerhans cell migration to the
draining lymph nodes in response to WNV are unknown.
Cytokines, however, involved in Langerhans cell migration in
response to contact sensitizers include tumor necrosis factor (TNF)
and interleukin (IL)-1b, thought to work separately, but in tandem.
This has been shown by intradermal injection of recombinant TNF
or IL-1b into the skin of BALB/C mice. Furthermore, systemically
administered neutralizing TNF and/or IL-1b antibodies inhibit
Langerhans cell migration from the epidermis to draining lymph
nodes in this model (Cumberbatch et al, 1997a, b).
Thus, in this study we investigated the possible role of TNF and
IL-1b in Langerhans cell migration from the epidermis to draining
lymph nodes following a cutaneous WNV infection in C57BL/6
TNF+/+ and TNF±/± mice. We show that in TNF±/± mice,
Langerhans cell migration in response to WNV is quantitatively
comparable with TNF+/+ controls, but that IL-1b is required.
Furthermore, we show that TNF is not required for WNV-
induced Langerhans cell migration in TNF+/+ mice.
MATERIALS AND METHODS
Animals Female C57BL/6 mice aged between 6 and 10 wk were
obtained from the Animal Resource Center (Perth, WA, Australia).
Female TNF-knockout mice (TNF±/±) bred on a C57BL/6 background
(Korner et al, 1997) aged between 6 and 10 wk were obtained from Dr.
Jonathon Sedgwick at the Centenary Institute of Cancer Medicine and
Cell Biology (Sydney, NSW, Australia). Animals infected with WNV
were housed in Hepa cages (Allentown Caging, NJ) and given access to
standard mouse food and distilled water ad libitum. All experiments were
conducted with approval from the University of Sydney Animal Ethics
Committee.
Virus infection WNV (Sarafend strain) was grown (King and Kesson,
1988; Shen et al, 1997) and used for cutaneous infection (Johnston et al,
2000) as previously described. Brie¯y, 4 ml of stock virus was seeded on
to washed monolayers of Vero cells cultured in 175 cm2 ¯asks (Nunc,
Roskilde, Denmark). Cultures were overlaid with 10 ml of Dulbecco's
minimal Eagle's medium (CSL, Melbourne, Victoria, Australia)
supplemented with 10% fetal bovine serum (CSL), and incubated for
60 min at 37°C 5% CO2. After a further 30 h incubation under these
conditions, the supernatant was removed and centrifuged to remove
cellular debris. The supernatants were then stored at ±70°C until
required. Titers of virus stocks were determined by serial dilutions on
Vero cell monolayers as previously described (Taylor and Marshall,
1975). Anesthetized mice (2,2,2-tribromo-ethanol; Aldrich Chemical,
Milwaukee, WI), were injected intradermally (i.d.) into the dorsal side of
their ears with 50 ml of WNV (approximately 5 3 105 PFU), using a 30
gauge needle (Becton Dickinson, Franklin Lakes, NJ). Control animals
were mock-infected with 50 ml of vehicle (Dulbecco's minimal Eagle's
medium with 10% fetal bovine serum from mock-infected vero cell
cultures). Mice were killed 12, 18, or 24 h later by cervical dislocation
and tissue was processed immediately.
Treatment of mice with neutralizing anti-TNF or anti-IL-1b
antibodies Mice received three 100 ml intraperitoneal (i.p.) injections
of neutralizing antibody 2 h prior to, at the time of, and 6 h after, WNV
injection. Wild-type C57BL/6 mice (TNF+/+) received 2 3 104
neutralizing units of polyclonal rabbit anti-mouse TNF in 100 ml
(Genzyme Diagnostics, Cambridge, MA) per injection. TNF±/± mice
received 20 mg of polyclonal goat anti-mouse IL-1b in 100 ml (R&D
Systems, Minneapolis, MN) per injection. Control mice received either
normal rabbit serum (Zymed Laboratories, San Francisco, CA) or total
goat IgG (R&D Systems). Antibodies were diluted at an equal IgG
concentration in phosphate-buffered saline (PBS). Mice were killed 18 h
after WNV or vehicle injection.
In vivo antibody neutralization of lipopolysaccharide (LPS) -
induced TNF or IL-1b release To con®rm that the anti-TNF and
anti-IL-1b antibodies successfully neutralized TNF and IL-1b,
respectively, in vivo, groups of three TNF+/+ or three TNF±/± mice that
had received anti-TNF or anti-IL-1b neutralizing or control antibody, as
described above, were injected i.p. with LPS (100 mg in 100 mL PBS)
derived from Escherichia coli (Sigma, St Louis, MO). These mice were
injected 2 h and 8±10 h after the ®nal anti-TNF and anti-IL-1b
antibody treatment, respectively. Mice were then carefully monitored for
signs of shock with the endpoint of both experiments being 18 h after
the second antibody injection. At this point, the mice were bled. The
level of serum TNF or IL-1b was determined by enzyme-linked
immunosorbent assay (ELISA) as previously described (Nakane et al,
1992). For the TNF ELISA, hamster anti-mouse TNF monoclonal
antibody (TN3; Genzyme Diagnostics) and rabbit anti-mouse TNF
polyclonal antibody (IP-400; Genzyme Diagnostics) were used as the
capture and detecting antibody, respectively. Antibody binding was
detected using biotinylated donkey anti-rabbit IgG (Sigma). The serum
level of bioactive TNF was also estimated by a cytotoxicity assay using
the TNF sensitive WEHI-164 cell line, as previously described (Espevik
and Nissen-Meyer, 1986; Rubel et al, 1998), using recombinant murine
TNF (Endogen, Woburn, MA) as a standard. For the IL-1b ELISA, an
IL-1b DuoSet was used (murine-IL-1b DuoSet; R&D Systems).
Identi®cation of Langerhans cells in draining lymph
nodes Subauricular ear skin draining lymph nodes were removed and
mechanically disrupted in 1 ml of Dulbecco's minimal Eagle's medium
with 10% fetal bovine serum using two 21 gauge hypodermic syringe
needles. Total cell counts were performed using a hemocytometer, with
dead cells being identi®ed by trypan blue (0.4%) dye exclusion. This was
to monitor lymph node shutdown, one of the ®rst indicators of initiation
of an immune response. Lymph node shutdown is characterized by an
increase in cellular input to the node, combined with an initial decrease
in cellular output, resulting in an increase in the total number of
leukocytes within the node (Smith and Morris, 1970; Cahill et al, 1974).
Langerhans cells in the draining lymph nodes were identi®ed by two-
color ¯ow cytometry analysis. Approximately 106 cells were placed in
glass tubes and centrifuged at 460 3 g for 3 min at 4°C. The pellet was
then resuspended in 50 ml of anti-E-cadherin rat IgG1 antibody (Decma-
1; Sigma) (Tang et al, 1993) and the anti-mouse I-A rat IgG2b antibody
TIB120 (American Type Culture Collection; ATCC; Rockville, MD) at
a concentration of 1±2 mg of antibody per 106 cells. The cells were
incubated with the antibodies for 45 min at 4°C, washed by underlaying
with 200 ml of fetal bovine serum and centrifuging at 460 3 g. The cells
were then incubated for 45 min at 4°C with goat anti-rat-IgG1-
¯uorescein isothiocyanate (RG11/39.4; PharMingen, San Diego) and
goat anti-rat-IgG2b-biotin (RG7/11.1; PharMingen). The cells were
washed and incubated with streptavidin±phycoerythrin (Jackson
Immunoresearch Laboratories, West Grove, PA) for 45 min at 4°C.
Isotype-matched control antibodies rat IgG1 (R3-34; PharMingen) and
rat IgG2b (R35-38; PharMingen) were used in parallel with the above
primary antibodies. All samples were acquired and analyzed using a
FACScalibur ¯ow cytometer and CellQuest software (Becton Dickinson,
Franklin Lakes, NJ). Files with 5 3 104 events were collected and
isotype controls were subtracted from positively stained cells to
determine the percentage of positive cells. E-cadherin+ cells were gated
using forward scatter vs ¯uorescence dot plots.
Owing to variability in ¯uorescence between different ¯ow cytometry
experiments, results for the number of E-cadherin+ Langerhans cells in
draining lymph nodes were normalized. To do this, Langerhans cell
migration in the control-treated WNV-infected groups (positive controls)
were regarded as ``100%'' migration, and all other levels of migration
were normalized against and then compared with this result.
Mathematically, normalization is as follows:
(a/b) 3 100
where a is the experimental value and b is the mean of the positive
control.
Identi®cation of Langerhans cells in epidermal sheets Twelve, 18,
or 24 h following injection of virus or vehicle, mice were killed and ears
surgically removed. Epidermal sheets were prepared as described
previously (Halliday et al, 1992). In brief, the dorsal surface of the ear
that was injected with virus was tape-stripped three to ®ve times with
cellophane tape (BDF Australia, Australia) to remove the stratum
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corneum. The ear was then cleaved along the cartilage and incubated in
PBS (pH 7.3) supplemented with 20 mM ethylenediamine tetraacetic
acid (Sigma) for 3 h at 37°C. The epidermis was mechanically separated
from the dermis and ®xed in acetone for 20 min at ±20°C. After
washing three times with PBS, the epidermis was incubated in
hybridoma supernatant containing anti-I-A antibody (TIB120) overnight.
The epidermis was then washed as above and incubated with
biotinylated goat anti-rat antibody (Caltag Laboratories, San Francisco,
CA) diluted in PBS containing 1% bovine serum albumin (PBS-bovine
serum albumin; Sigma) for 2 h. After this the epidermis was washed as
above and incubated with streptavidin±alkaline phosphatase (Amersham,
Buckingham, U.K.) in PBS-bovine serum albumin for 1 h. The
epidermal sheets were then washed again as above and incubated in a
New Fuchsin-based substrate for 20 min. All incubations were
performed at room temperature. Following washing with distilled water,
the epidermal sheets were placed on glass microscope slides, air dried,
and mounted in Histomount (National Diagnostics, Riverstone, NSW,
Australia). Stained epidermal sheets were blinded and counted using a
true color, fully automated image analysis system (Chromatic Color
Image Analysis System, LR. Javis, Wild-Leitz, Sydney, NSW, Australia).
For each epidermal sheet, randomly selected ®elds were counted until
the total area evaluated approximated 1 mm2. Isotype controls were
included to ensure speci®city of staining.
Data analysis Statistical differences between groups was assessed by
ANOVA, which will take into account variability between groups. For
analysis of ELISA data, an unpaired Student's t test was used. In both
methods, values of p < 0.05 were considered signi®cant.
RESULTS
WNV induces a reduction in epidermal Langerhans cells and
an increase in lymph node Langerhans cells in both TNF+/+
and TNF±/± mice To investigate the role of TNF in Langerhans
cell migration from C57BL/6 skin in response to WNV, groups of
wild-type (TNF+/+) and TNF knockout (TNF±/±) mice were each
infected with WNV or mock infected, and the frequencies of
Langerhans cells, both in the epidermis and the draining lymph
nodes, were determined at various time points. The epidermis of
mock-infected TNF±/± mice contained signi®cantly higher
numbers of Langerhans cells (700 per mm2), when compared
with similarly treated TNF+/+ mice (550 per mm2). In TNF+/+
mice, WNV caused a signi®cant reduction in the density of
epidermal Langerhans cells at 18 h, but not 12 or 24 h after
infection (Fig 1). Interestingly, a reduction in Langerhans cells
Figure 2. WNV causes morphologic changes
in epidermal Langerhans cells. Epidermal
sheets from 18 h WNV-infected or mock-infected
TNF+/+ and TNF±/± mice were stained for MHC
class II. TNF+/+ (A) or TNF±/± mice (B) treated
with vehicle display long extended dendrites.
Control IgG treated, TNF±/± mice infected with
WNV (C) display a more activated appearance
with smaller dendrites and rounded cell bodies
when compared with vehicle controls. Anti-IL-1b
treated WNV-infected TNF±/± mice (D) had
reduced numbers of Langerhans cells with an
activated appearance compared with control IgG
treated WNV-infected mice (C). Scale bar: 50 mm.
Figure 1. WNV causes a reduction in epidermal Langerhans cells in both TNF+/+ and TNF±/± mice. C57BL/6 wild-type (TNF+/+) and
TNF knockout (TNF±/±) mice were injected with WNV or vehicle control. Twelve, 18, or 24 h postinfection, epidermal sheets were prepared and
stained for Langerhans cells with anti-MHC II antibody. Langerhans cells were enumerated by image analysis. For 12 h and 24 h time points, results
were pooled from two separate experiments. For the 18 h time point, results are a pool of three separate experiments. All results are presented as
mean 6 SEM, and were statistically analyzed by ANOVA. NS, not signi®cant. The number of injected ears per group (n) is indicated below the x-axis.
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density in response to WNV infection was observed in TNF±/±
mice with similar kinetics. At 18 h, but not at the 12 and 24 h
time-points, some of the Langerhans cells in WNV-infected
TNF+/+ and TNF±/± mice displayed a more activated appearance
with smaller dendrites and rounded cell bodies compared with
mock-infected mice (Fig 2).
Flow cytometry was used to detect E-cadherin+ Langerhans cells
in the draining lymph nodes as described previously (Johnston et al,
2000). Pooled lymph node cell suspensions from TNF+/+ mice
injected with either vehicle (Fig 3A, B, G) or WNV (Fig 3C, D,
F, H), were double-labeled with anti-MHC class II and anti-E-
cadherin antibodies (Fig 3B, D, G, H) (or appropriate isotype-
matched control antibodies) (Fig 3A, C, F). In these samples, all E-
cadherin+ cells expressed high levels of MHC class II antigens. On
back-gating, these double-positive cells had forward vs side-scatter
pro®les typical of DC (data not shown). Moreover, when this high
forward scatter vs high side scatter population was forward-gated
(Fig 3E), these cells were MHC class IIhigh and E-cadherin+
(Fig 3F, G, H). Very small numbers of cells were detectable in
mice that received vehicle (Fig 3G), but a clear population of
MHC class IIhigh and E-cadherin+ cells were detected in WNV-
infected mice (Fig 3H). Similar results were observed in TNF±/±
mice (data not shown). This indicates that E-cadherin can be used
to detect epidermally derived DC in draining lymph nodes.
Signi®cantly higher numbers of E-cadherin+ Langerhans cells in
the draining lymph nodes of WNV-infected, compared with
mock-infected animals, were observed at all time points (12, 18, or
24 h) in both wild-type and knockout mice (Fig 4). There was no
statistically signi®cant difference between TNF+/+ and TNF±/±
mice at any of these time points.
WNV-infected groups of TNF+/+ and TNF±/± mice had
signi®cantly higher total numbers of lymph node cells than
mock-infected mice at all time points (Fig 5), indicating that
lymph node shut-down occurred in conjunction with the appear-
ance of E-cadherin+ Langerhans cells in the draining lymph nodes.
Neutralizing anti-TNF antibody does not inhibit
Langerhans cell migration in TNF+/+ mice Wild-type
C57BL/6 (TNF+/+) mice were injected with anti-TNF
neutralizing antibodies or control serum prior to infection with
WNV or vehicle control as described. Neutralization by anti-TNF
antibody was con®rmed in TNF+/+ mice by measuring serum
levels of TNF in response to LPS (Table I). Anti-TNF antibody
signi®cantly reduced the levels of LPS-induced TNF in mouse
serum. These ELISA results were further con®rmed by bioassay
(data not shown). Epidermal Langerhans cells, lymph node
Langerhans cells, and total lymph node cell numbers were
determined 18 h after infection. Figure 6 shows that anti-TNF
neutralization did not inhibit WNV-induced Langerhans cell
migration in TNF+/+ mice. In mice that received neutralizing
anti-TNF or control antibody, the density of epidermal Langerhans
cells decreased in each to a similar extent. Furthermore, in both
groups, there was a signi®cant increase in the number of E-
cadherin+ Langerhans cells found in the draining lymph nodes after
WNV infection, compared with mock infection. Mice infected
with WNV and treated with neutralizing anti-TNF or control
antibody had a signi®cant increase in total lymph node cell numbers
compared with their respective controls, suggesting that lymph
node shutdown was independent of TNF (Fig 6).
Epidermal Langerhans cell migration and accumulation in
the draining lymph nodes of TNF±/± mice is dependent on
IL-1b IL-1b, in concert with TNF, has been shown to be
involved in epidermal Langerhans cell migration to the lymph
nodes in response to contact sensitizers (Cumberbatch et al, 1997a,
b). Therefore, to investigate the role of IL-1b alone in the
migration of Langerhans cells after WNV infection, TNF±/± mice
were pretreated with neutralizing anti-IL-1b or control IgG prior
to WNV or mock infection. Hence, the actions of both TNF and
IL-1b were blocked in these experiments. Neutralization by anti-
IL-1b antibody was con®rmed in TNF±/± mice by measuring
serum levels of IL-1b in response to LPS by ELISA (Table I). This
treatment reduced IL-1b levels during LPS stimulation back to the
Figure 3. Langerhans cells in the draining lymph nodes of WNV-
infected mice express high levels of both E-cadherin and MHC
class II molecules. Lymph node cell suspensions were prepared from
TNF+/+ mice infected with vehicle or WNV for 18 h. Cells were
stained with anti-E-cadherin and anti-MHC II antibodies (or isotype
control antibodies) and analyzed by ¯ow cytometry. Parts (A)±(D) show
ungated populations of lymph node cells. Numbers in each ®gure show
statistics for the right upper quadrant. These represent the absolute
number of cells in the sample of 50,000 events and the absolute
percentage of cells. Part (E) shows the gate (R2) used to select events
with high forward vs high side scatter typical of DC. Parts (F)±(H) show
events within R2 only. Numbers in each ®gure show the absolute
number of events in R2, absolute percentage of cells and percentage of
cells within R2, from top to bottom, respectively. Representative data
are shown here, and these were similar in three replicate experiments.
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approximate limits of detection using this ELISA. Epidermal
Langerhans cells, lymph node Langerhans cells and total lymph
node cell numbers were determined 18 h after infection. The
results in Fig 7 show that Langerhans cell migration from the
epidermis in response to viral infection is reduced by treatment
with anti-IL-1b antibody. Control IgG-treated, but not IL-1b-
neutralized mice, showed a signi®cant reduction in numbers of
epidermal Langerhans cells in response to cutaneous WNV
infection. Thus there were signi®cantly larger numbers of
Langerhans cells in the epidermis of WNV-infected, IL-1b-
treated mice, compared with WNV-infected control IgG-treated
animals. Interestingly, when comparing the two vehicle-injected
groups in these experiments, there was a signi®cant difference
(p = 0.0413) between anti-IL-1b-treated and control IgG-treated
Langerhans cells densities. Analysis of lymph node Langerhans cells
showed that whereas WNV increased the numbers of Langerhans
cells in both control (3-fold increase) and anti-IL-1b-treated mice
(2-fold increase), compared with each other, there were
signi®cantly fewer Langerhans cells in the lymph nodes of anti-
IL-1b-treated mice (p = 0.0034). Total lymph node cell numbers
were also signi®cantly lower in the WNV-infected anti-IL-1b
antibody group compared with WNV-infected control IgG
TNF±/± mice (p = 0.0179).
DISCUSSION
The cytokines, TNF and IL-1b, have been implicated in
Langerhans cell migration to draining lymph nodes in response to
contact sensitizers (Cumberbatch et al, 1997a). This study exam-
ined the role of these two cytokines in Langerhans cell migration in
response to a replicating, cutaneously acquired arbovirus, WNV, in
C57BL/6 TNF+/+ and TNF±/± mice. Eighteen hours after
cutaneous WNV infection in vivo, we found a signi®cant reduction
in epidermal Langerhans cell numbers, a corresponding signi®cant
increase in Langerhans cell numbers in the draining lymph node, as
well as lymph node shutdown, compared with mock-infected
controls. Interestingly, there was no difference in these parameters
between TNF+/+ and TNF±/± groups in their response to WNV
infection. Systemic administration of neutralizing anti-TNF anti-
bodies in WNV-infected TNF+/+ mice failed to inhibit Langerhans
cell migration following WNV infection in these mice, further
supporting the ®ndings in TNF±/± mice that TNF was not involved
in Langerhans cell migration. On the other hand, IL-1b
neutralization signi®cantly inhibited emigration of Langerhans
cells from the epidermis, appearance of Langerhans cells in the
lymph node, and lymph node shutdown in WNV-infected TNF±/±
mice. Whereas previous reports show that TNF plays a crucial part
in Langerhans cell migration in response to contact sensitizers
Figure 4. WNV increases the number of Langerhans cells in draining lymph nodes of TNF+/+ and TNF±/± mice. TNF+/+ and TNF±/±
mice were injected with WNV or vehicle control. The draining lymph nodes were removed and analyzed for E-cadherin+ Langerhans cells by ¯ow
cytometry 12, 18, or 24 h postinfection. Results from three separate experiments were normalized to the WNV-treated TNF+/+ groups, presented as
mean 6 SEM, and were statistically analyzed by ANOVA. The number of nodes per group (n) is indicated below the x-axis. There was no signi®cant
difference between control groups for Langerhans cells/node.
Figure 5. Total lymph node cell numbers increase with time
after WNV infection in both TNF+/+ and TNF±/± mice. TNF+/+
and TNF±/± mice were injected with WNV or vehicle control. Twelve,
18, or 24 h postinfection, the total number of cells in the draining
lymph nodes were quantitated using a hemocytometer, with dead cells
being excluded with trypan blue (0.4%). Results were pooled from two
separate experiments, presented as mean 6 SEM, and were statistically
analyzed by ANOVA. p-values are compared with the relevant controls at
the same time point.
Table I. Neutralizing anti-TNF and anti-IL-1b antibodies
successfully neutralized LPS induced serum TNF or IL-1b
as measured by ELISA
Treatment
Control-treated Antibody-treated
TNF (pg per ml) 815 6 209a 101 6 7 (p < 0.05)b
IL-1b (pg per ml) 402 6 43 240 6 10 (p < 0.05)
aMean cytokine levels (pg per ml) 6 SEM for three mice/group.
bStatistical analysis was done by the Student's t test with p < 0.05 considered
signi®cantly different.
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(Kimber and Cumberbatch, 1992; Cumberbatch et al, 1994; Wang
et al, 1996), some groups have described similar ®ndings to those
described here (Stoitzner et al, 1999). These results were obtained
using an in vitro migration system and showed that normal
migration of DC occurred in skin explants taken from TNF/
lymphotoxin-de®cient C57BL/6 mice. In relation to this study,
these results corroborate our ®ndings that in response to a
cutaneous-acquired viral infection, TNF is not crucial. In most
in vivo studies, contact sensitizers are used to induce Langerhans cell
migration, whereas in this study we used a live, replicating virus,
which may utilize different signals to induce Langerhans cell
migration. Moreover, previous studies have mostly been in BALB/
C mice, whereas we have used C57BL/6 mice in this study. The
work presented here has produced results that appear to contradict
those found by Cumberbatch et al (1994, 1997a, b). Rather, we
believe that our unique model of virally induced Langerhans cell
migration has only reinforced the crucial part that TNF and IL-1b
plays in mediating Langerhans cell migration in response to a
variety of cutaneous-acquired infections. Thus, although our model
is unique, it has not withstanding a more universal application. The
use of a second strain has highlighted the range of overlapping
function in cytokines related to Langerhans cell migration and
illustrates the necessity to canvas more than one mouse strain for
de®nitive results. By exploring the variety of possibilities, namely
using genetically different inbred strains of mice, we hopefully can
also further our understanding of the range of possible responses in
humans.
Reports over the last 2 decades indicate clear differences between
BALB/C and C57BL/6 mice. Differences in the TNF locus are
proposed to account for sensitivity to ultraviolet-induced im-
munosuppression between BALB/C (ultraviolet-resistant) and
C57BL/6 (ultraviolet-susceptible) mice (Streilein and Bergstresser,
1988). In vitro, IL-1a and TNF are not required by C57BL/6 DC
to drive IL-12-dependent Th1 development when antigen is
presented, whereas BALB/C DC are unable to activate Th1 cells
without these cytokines (Shibuya et al, 1998). It is therefore
possible that Langerhans cells in these strains migrate preferentially
in response to different cytokines. Our results clearly indicate that
TNF is not required for Langerhans cell migration in response to
WNV in C57BL/6 mice.
In BALB/C mice, IL-1b also mediates Langerhans cell migra-
tion, in tandem with TNF (Cumberbatch et al, 1997a, b).
Figure 7. Neutralizing anti-IL-1b antibody inhibits Langerhans cell migration from the epidermis and accumulation in the draining
lymph nodes of TNF±/± mice at 18 h. Groups of TNF±/± mice were treated with either control serum (Cont IgG) or anti-IL-1b neutralizing serum
(aIL-1b) and injected with WNV or vehicle control. Eighteen hours after WNV infection, mice were killed and analyzed for epidermal Langerhans
cell density, E-cadherin+ Langerhans cells in draining lymph nodes, and total lymph node cell number. The number of nodes or sheets per group (n) is
indicated below the x-axis. Results were pooled from three separate experiments for epidermal Langerhans cells, normalized and pooled from ®ve
separate experiments for E-cadherin+ Langerhans cells in lymph nodes. Five separate experiments were pooled for total lymph node numbers. Results
are presented as mean 6 SEM, and were statistically analyzed by ANOVA. There was no signi®cant difference between control groups for Langerhans
cells/node. (*indicates p < 0.05 comparing the two control groups for Langerhans cell densities).
Figure 6. Neutralizing anti-TNF antibody does not inhibit Langerhans cell migration from the epidermis or accumulation in the
draining lymph nodes of TNF+/+ mice at 18 h. Groups of TNF+/+ mice were treated with either control serum (NRS) or anti-TNF neutralizing
serum (aTNF) and injected with WNV or vehicle control (see Materials and Methods). Eighteen hours after WNV infection, mice were killed and
analyzed for epidermal Langerhans cell density, E-cadherin+ Langerhans cells in draining lymph nodes, and total lymph node cell number. For all
groups, n = 8. Results were pooled from two separate experiments, are presented as mean 6 SEM, and were statistically analyzed by ANOVA. There
was no signi®cant difference between control groups for Langerhans cells/node.
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Application of the contact sensitizer, trinitrochlorobenzene, to
BALB/C skin increases the mRNA expression of IL-1b in
epidermal Langerhans cells (Enk et al, 1993) and IL-1b decreases
E-cadherin expression preceding Langerhans cell migration out of
the epidermis (Jakob and Udey, 1998). Mice de®cient in IL-1b
have impaired contact hypersensitivity to trinitrochlorobenzene
(Shornick et al, 1996). Interestingly, IL-1b, but not TNF has been
shown to enhance the migration of human Langerhans cells in a
skin explant culture system (Rambukkana et al, 1996). Our results
indicate that IL-1b mediates Langerhans cell migration to the
draining lymph nodes and lymph node shutdown in response to
cutaneous WNV infection in C57BL/6 mice in the absence of
TNF. These outcomes were signi®cantly inhibited but not
completely blocked by high concentrations of systemically admin-
istered neutralizing antibody to IL-1b (3-fold vs 2-fold increase in
Langerhans cell migration for control-treated and antibody-treated
TNF±/± animals, respectively). These ®ndings are consistent with
those found by Stoitzner et al (1999) in that they were also able to
inhibit but not completely block Langerhans cell migration in vitro
with anti-IL-1b antibodies. Failure to abrogate these completely
may have a technical basis or may indicate that there are yet other
cytokines that mediate or augment these activities in this strain.
The identity of Langerhans cells in the epidermis was made by
MHC class II staining and morphologic criteria at light microscopy;
those reaching the draining lymph node were identi®ed ¯ow
cytometrically, using two-color MHC II and E-cadherin labeling.
E-cadherin anchors Langerhans cells to keratinocytes in the
epidermis (Udey, 1997). It is downregulated when Langerhans
cells are activated by antigen, enabling them to migrate out of the
epidermis (Tang et al, 1993). Used with MHC II, it is a reliable
marker for lymph node Langerhans cells, as only those MHC II+
Langerhans cells that have migrated from the epidermis display E-
cadherin and, although downregulated, levels of E-cadherin are
readily detectable by ¯ow cytometry (Borkowski et al, 1994;
Blauvelt et al, 1995; Johnston et al, 2000).
In both TNF+/+ and TNF±/± groups, the density of epidermal
Langerhans cells decreased only transiently, and returned to baseline
levels by 24 h following WNV infection. Langerhans cells are
continually replenished from bone marrow precursors and it is
likely that repopulation returned epidermal Langerhans cell num-
bers to normal by 24 h. Similar bone marrow precursor renewal of
the airway DC population also occurs (Holt et al, 1994); however,
a signi®cant difference was observed in baseline epidermal
Langerhans cell densities between TNF+/+ and TNF±/± mice.
Previous studies have implicated TNF in the differentiation and
recruitment of human DC precursors (Caux et al, 1993). Recent
evidence suggests that the CC chemokine, macrophage in¯amma-
tory protein 3a (MIP-3a) is important in the localization of
Langerhans cell precursors to the epidermis (Charbonnier et al,
1999), whereas MIP-3b is important in the traf®cking of
Langerhans cells to the draining lymph nodes (Kellermann et al,
1999). As TNF downregulates the surface expression of CCR6, the
receptor for MIP-3a (Carramolino et al, 1999), TNF±/± mice may
recruit more Langerhans cell precursors in to the epidermis,
resulting in higher baseline Langerhans cell densities. We are
currently investigating these possibilities.
It can be seen in Fig 7 that treatment of vehicle-injected
(negative control) TNF±/± mice with anti-IL-1b resulted in lower
Langerhans cells densities than mice treated with control IgG. This
result may be explained by data from a recent study by Homey et al
(2000) that shows that keratinocytes upregulate MIP-3a in
response to IL-1b. As MIP-3a recruits Langerhans cells to the
skin, our data suggests that anti-IL-1b antibody inhibited
the continuing recruitment of Langerhans cell precursors into the
epidermis in this experiment, resulting in the discrepancy in
epidermal Langerhans cell numbers between the vehicle-injected,
anti-IL-1b-treated, and control IgG-treated mice.
It follows that if anti-IL-1b antibody were not inhibiting
emigration of Langerhans cells from the epidermis in WNV-
infected mice, there would be a greater reduction in epidermal
Langerhans cell numbers in the WNV-infected, anti-IL-1b anti-
body-treated mice, compared with the WNV-infected, control
IgG-treated mice. Our results, however, showed that this antibody
signi®cantly inhibited the WNV-induced emigration of Langerhans
cells from the epidermis, compared with both the WNV-infected,
control IgG-treated and the vehicle-injected, anti-IL-1b antibody-
treated groups.
The mechanisms of cytokine-induced Langerhans cell migration
and lymph node shutdown are not fully understood. Lymph node
shutdown (Smith and Morris, 1970; Cahill et al, 1974; Hay and
Hobbs, 1977) increases the peripheral T cell pool in the node, thus
increasing the likelihood of an antigen-presenting Langerhans cell
coming into contact with antigen-speci®c T cells. In this study,
lymph node shutdown was contemporaneous with the appearance
of Langerhans cells from WNV-infected skin in the draining node
in WNV-infected but not vehicle-injected control mice.
Neutralizing IL-1b antibodies in TNF±/± mice inhibited both
Langerhans cell migration and lymph node shutdown. Thus
whether Langerhans cell mobilization triggered lymph node
shutdown, or whether IL-1b was independently responsible, is
not known.
Recent evidence suggests that chemokines may play an import-
ant part in DC migration and traf®cking. Sozzani et al (1998)
showed that DC activated with IL-1, TNF, LPS, or CD40L had a
strongly augmented chemotactic response to EBI1 ligand chemo-
kine. Others have shown enhanced in vitro migration of human DC
to MIP-3b and the CXC chemokine, stromal cell derived factor-
1a, following preculture of DC with TNF, LPS, or IL-1b (Lin
et al, 1998). In a contact sensitizer model, Yamazaki et al (1998)
demonstrated that the chemokines RANTES (Regulated on
activation, normal T-expressed and secreted) and monocyte
chemoattractant protein-1, as well as TNF, were able to stimulate
Langerhans cell migration. Thus, it is likely that IL-1b in¯uences
Langerhans cell migration via both direct and indirect mechanisms.
Further experiments are required, however, to establish whether
chemokines are involved in the WNV-induced Langerhans cell
migration studied here.
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